Add-on tiotropium: clinical improvement of moderate asthma regardless of baseline ige/eosinophil status across age groups

The influence of biomarker status on add-on tiotropium efficacy was analyzed across age groups using data from four phase 3 clinical trials.

Source: Annals of Allergy, Asthma and Immunology - November 1, 2018 Category: Allergy & Immunology Authors: E. Meltzer, T. Casale, A. Shaikh, L. Zaremba-Pechmann Tags: P213 Source Type: research